Wyoming Clinical Trials
Browse actively recruiting clinical trials with research sites in Wyoming. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Wyoming
- Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and RadiationNCT07615049PHASE3SWOG Cancer Research NetworkRecurrent Soft Tissue Sarcoma of the Trunk and Extremities
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196PHASE2National Cancer Institute (NCI)Clinical Stage III Cutaneous Melanoma AJCC v8
- Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)NCT06672146PHASE2National Cancer Institute (NCI)Acute Myeloid Leukemia
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisNCT07697456PHASE2AbbVieCrohn's Disease
- Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangeNCT03191149PHASE2National Cancer Institute (NCI)Advanced Lung Non-Small Cell CarcinomaCheyenne, WY
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerNCT04628767PHASE2, PHASE3National Cancer Institute (NCI)Renal Pelvis and Ureter Urothelial Carcinoma
- Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialNCT06770582PHASE2National Cancer Institute (NCI)Non-Muscle Invasive Bladder Urothelial Carcinoma
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisNCT07415044PHASE2Eli Lilly and CompanyUlcerative Colitis (UC)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)NCT06917911PHASE2National Cancer Institute (NCI)Core Binding Factor Acute Myeloid Leukemia
- Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)NCT06577441PHASE2National Cancer Institute (NCI)Myelodysplastic Syndrome
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844PHASE3National Cancer Institute (NCI)Advanced Lung Non-Small Cell Carcinoma
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialNCT06498635PHASE3National Cancer Institute (NCI)Lung Non-Small Cell Carcinoma
Popular conditions in Wyoming
Frequently asked questions
- How do I find clinical trials in Wyoming?
- Corterve aggregates actively recruiting clinical trials with sites in Wyoming from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Wyoming free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Wyoming?
- Wyoming research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.